These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 30612001)

  • 1. Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease.
    Tan SH; Karri V; Tay NWR; Chang KH; Ah HY; Ng PQ; Ho HS; Keh HW; Candasamy M
    Biomed Pharmacother; 2019 Mar; 111():765-777. PubMed ID: 30612001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
    Xie A; Gao J; Xu L; Meng D
    Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?
    Ross JM; Olson L; Coppotelli G
    Int J Mol Sci; 2015 Aug; 16(8):19458-76. PubMed ID: 26287188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease.
    Ganguly G; Chakrabarti S; Chatterjee U; Saso L
    Drug Des Devel Ther; 2017; 11():797-810. PubMed ID: 28352155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
    Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
    Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial retrograde signaling in the nervous system.
    Hunt RJ; Bateman JM
    FEBS Lett; 2018 Mar; 592(5):663-678. PubMed ID: 29086414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
    Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin and Neurodegenerative Disorders-a Review.
    Shi L; Du X; Jiang H; Xie J
    Mol Neurobiol; 2017 Mar; 54(2):1144-1155. PubMed ID: 26809582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers.
    Mesa-Herrera F; Taoro-González L; Valdés-Baizabal C; Diaz M; Marín R
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitophagy Regulates Neurodegenerative Diseases.
    Cen X; Zhang M; Zhou M; Ye L; Xia H
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
    Shacka JJ; Roth KA; Zhang J
    Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular changes in the postmortem parkinsonian brain.
    Toulorge D; Schapira AH; Hajj R
    J Neurochem; 2016 Oct; 139 Suppl 1():27-58. PubMed ID: 27381749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Free radical processes in aging, neurodegenerative diseases and other pathological states].
    Dubinina EE; Pustygina AV
    Biomed Khim; 2007; 53(4):351-72. PubMed ID: 18035718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.
    Monzio Compagnoni G; Di Fonzo A; Corti S; Comi GP; Bresolin N; Masliah E
    Mol Neurobiol; 2020 Jul; 57(7):2959-2980. PubMed ID: 32445085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Oxidative Stress Mechanisms to Treat Alzheimer's and Parkinson's Disease: A Critical Review.
    Aborode AT; Pustake M; Awuah WA; Alwerdani M; Shah P; Yarlagadda R; Ahmad S; Silva Correia IF; Chandra A; Nansubuga EP; Abdul-Rahman T; Mehta A; Ali O; Amaka SO; Zuñiga YMH; Shkodina AD; Inya OC; Shen B; Alexiou A
    Oxid Med Cell Longev; 2022; 2022():7934442. PubMed ID: 35958022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration.
    Deza-Ponzio R; Herrera ML; Bellini MJ; Virgolini MB; Hereñú CB
    Neurotoxicology; 2018 Sep; 68():19-24. PubMed ID: 29936317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.